Login / Signup
Fengming Yi
ORCID
Publication Activity (10 Years)
Years Active: 2019-2023
Publications (10 Years): 8
Top Topics
Ejection Fraction
Combination Therapy
Papillary Thyroid
Emergency Department
Top Venues
Canadian journal of gastroenterology & hepatology
Journal of oncology
Gastroenterology research and practice
BMC gastroenterology
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Jiabing Wang
,
Haoqian Xu
,
Ying Wang
,
Long Feng
,
Fengming Yi
Efficacy and Safety of Drug-Eluting Bead TACE in the Treatment of Primary or Secondary Liver Cancer.
Canadian journal of gastroenterology & hepatology
2023 (2023)
Yanyan Ye
,
Ying Wang
,
Haoqian Xu
,
Fengming Yi
Network meta-analysis of adjuvant treatments for patients with hepatocellular carcinoma after curative resection.
BMC gastroenterology
23 (1) (2023)
Jiabing Wang
,
Haoqian Xu
,
Ying Wang
,
Long Feng
,
Fengming Yi
Efficacy and Safety of Drug-Eluting Bead TACE in the Treatment of Primary or Secondary Liver Cancer.
Canadian journal of gastroenterology & hepatology
2023 (2023)
Jiabing Wang
,
Haoqian Xu
,
Ying Wang
,
Long Feng
,
Fengming Yi
Efficacy and Safety of Drug-Eluting Bead TACE in the Treatment of Primary or Secondary Liver Cancer.
Canadian journal of gastroenterology & hepatology
2023 (2023)
Long Feng
,
Ying Wang
,
Haoqian Xu
,
Fengming Yi
Comparison of Different First-Line Systemic Therapies in Advanced Biliary Tract Cancer Based on Updated Random Controlled Trials: A Systematic Review and Network Meta-Analysis.
BioMed research international
2022 (2022)
Wei Yu
,
Qiaomeng Tao
,
Yufeng Zhang
,
Fengming Yi
,
Long Feng
Efficacy and Safety of Regorafenib Combined with Toripalimab in the Third-Line and beyond Treatment of Advanced Colorectal Cancer.
Journal of oncology
2021 (2021)
Fengming Yi
,
Longxiang Xin
,
Long Feng
Potential mechanism of circRNA_000585 in cholangiocarcinoma.
The Journal of international medical research
49 (6) (2021)
Ying Wu
,
Danyang Zhou
,
Guoping Zhang
,
Fengming Yi
,
Long Feng
Preoperative Serum Platelet-Lymphocyte Ratio as a Prognostic Factor in Cholangiocarcinoma Patients after Radical Resection: A Retrospective Analysis of 119 Patients.
Gastroenterology research and practice
2019 (2019)